To investigate whether LRP5 and sclerostin are present in placental tissue and are associated with GDM, we examined the expression of these 2 molecules at the maternal site of placentas of pregnant women with GDM in comparison to placentas of healthy, nondiabetic pregnant women. The gene discussed is LRP5; the disease is gestational diabetes.